BioPhorum Advanced Therapy Medicinal Products
BioPhorum Advanced Therapy Medicinal Products (ATMP) supports our members to advance their cell, gene, and RNA therapies and vaccines. We work with developers, contract manufacturing, and testing organizations to streamline the industry for all.
The advanced therapeutics industry is facing several challenges that need a collaborative approach. Bringing your cell, gene, and RNA therapy developments to market and avoiding regulatory delays in this exciting area of pharmaceuticals is key to developing new business.
Join over 34 members at the cutting edge of advanced therapy to increase the speed and quality of your cell, gene and RNA products. By working with industry experts, you can put your organization at the forefront of this exciting new area of biopharmaceuticals.
BioPhorum ATMP supports its members through five key challenges:
- Speed of development and product to market
- Improving existing commercial manufacturing processes
- Analytics and standards
- Regulatory challenges
- Understanding the challenges from the evolving industry landscape
To tackle these broad challenges, we have high-level workstreams looking at industry trends.
These high-level workstreams are split across dedicated modality-focused areas (cell therapy; ex vivo gene therapy; in vivo gene therapy; and RNA) and across functionality-focused areas (development; analytics; commercialization; regulatory; EHS and biosafety; raw materials; and talent). There are additional in-depth workstreams drilling down into specific challenges. ATMP members continue to identify new workstreams to support the advance therapeutics arena.
Improving how our members develop, control, and manufacture these life-changing therapies through industry collaboration is more important than ever. The advanced therapies field continues to mature and learn. While there has been a downturn in record-breaking funding, there is a push for expansion and a growing list of approved products.
BioPhorum ATMP, together with our members, is addressing the specific challenges within the wider five areas above. This will bring alignment on aspects of advanced therapy development and manufacturing to drive standardization across the industry.
The phorum program supports companies developing, manufacturing, and testing these advanced therapies. Our high-level workstreams create discussion, innovation, and quickly address issues. Plus, the in-depth workstreams focus on delivering positive outcomes for specific challenges which shape the industry.
Our members gain huge value through working together to:
- Develop responses to the challenges faced within advanced therapies
- Improve robustness, efficiency, and consistency of development and manufacture
- Establish industry standards and influence regulatory position
- Share challenges, experience, and benchmark across the industry
- Develop tools to support the advanced therapies industry
Additionally, our members have access to methodologies, research, and tools ahead of publication.
Phorum members have presented at conferences and webinars, published in newsletters, provided feedback on regulatory guidelines and produced members-only tools, benchmarks and guidance. We continue building links with ASTM International, the US Pharmacopeia, the Standards Coordinating Body, and the British Pharmacopeia and Medicines and Healthcare Products Regulatory Agency developing strong ties with these organizations.
The advanced therapies business is as diverse as the patients it serves, so there are no one-size-fits-all solutions. However, by driving harmonization and alignment in this new industry, the Phorum promotes better and faster development of therapies.
Contact BioPhorum Advanced Therapy Medicinal Products
To find out more about how BioPhorum BioPhorum Advanced Therapy Medicinal Products can help your business, enter your details below and a member of our team will be in touch.